+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Spheroids Market Size, Share & Trends Analysis Report by Type, Method, Source, Application (Developmental Biology, Personalized Medicine, Regenerative Medicine), End-use, Region and Segment Forecasts, 2025-2030

  • PDF Icon

    Report

  • 120 Pages
  • May 2025
  • Region: Global
  • Grand View Research
  • ID: 6098210
REQUEST CUSTOMIZATION
Description Jump to:
The Spheroids Market was valued at USD 749.9 million in 2024, and is projected to reach USD 2.46 billion by 2030, rising at a CAGR of 22.70%. The market has gained significant traction due to the growing demand for advanced 3D cell culture models that offer more physiologically relevant conditions than traditional 2D cultures. Spheroids, which better mimic the cellular architecture, nutrient gradients, and microenvironment of tissues in vivo, are increasingly used in drug screening, disease modeling, toxicology testing, and regenerative medicine. Their application spans a wide range of therapeutic areas, including oncology, neurology, and metabolic diseases, as researchers and pharmaceutical companies prioritize more accurate preclinical models to improve drug development success rates and reduce late-stage failures.

Another major driver is the integration of spheroids into high-throughput screening (HTS) systems, enabling pharmaceutical and biotechnology companies to evaluate large compound libraries with greater predictive value. The market is also fueled by developing novel tools and technologies such as low-attachment plates, hanging drop systems, and microfluidic platforms that simplify spheroid generation and improve reproducibility. In addition, increased funding from government agencies and private investors has supported the expansion of 3D culture research in academic and commercial settings.

The COVID-19 pandemic further accelerated the adoption of spheroid models, particularly in virology and immunology research. As researchers sought models that more closely represented human tissues, spheroids proved valuable for studying SARS-CoV-2 infection mechanisms, host immune responses, and antiviral drug efficacy. The pandemic highlighted the limitations of conventional 2D cultures and animal models in rapidly understanding complex diseases, leading to increased investment in 3D culture technologies, including spheroids. This shift also supported long-term market growth as laboratories increasingly adopted advanced culture systems to future-proof research infrastructure.

Post-pandemic, the momentum around spheroids has continued, driven by a global push toward more ethical and efficient preclinical testing strategies. Regulatory agencies and research institutions increasingly recognize the value of spheroids and other 3D models in reducing animal testing while improving translational outcomes. Furthermore, the rise of personalized medicine and the use of patient-derived cells to form disease-specific spheroids are opening new opportunities for customized drug development and therapeutic testing. Together, these factors are shaping a robust outlook for the market in the years ahead.

Spheroids Market Report Highlights

  • The multicellular tumor spheroids (MCTS) segment accounted for the largest revenue share of 28.91% in 2024 and is expected to have the fastest growth rate over the forecast period. MCTS closely replicates the in vivo tumor microenvironment, enabling more accurate cancer research and drug screening. Their ability to model tumor heterogeneity and drug resistance drives their adoption in oncology-focused studies.
  • The hanging drop method segment accounted for the largest revenue share of 31.34% in 2024 and is expected to have the fastest growth rate over the forecast period. This simple and cost-effective technique facilitates uniform spheroid formation without scaffolds, ideal for controlled experimental setups. Its ease of use and compatibility with high-throughput systems support widespread research adoption.
  • The cell line segment accounted for a larger revenue share of 56.64% in 2024. Cell lines are a major market driver because they provide a standardized, reproducible, and cost-effective resource for generating 3D spheroid models across a wide range of research applications.
  • The regenerative medicine segment is expected to witness the highest CAGR over the forecast period. Spheroids enhance tissue engineering by promoting cell-cell interactions and mimicking native tissue structures. Their role in developing functional tissue constructs makes them essential in regenerative therapies.
  • The biotechnology and pharmaceutical industries segment accounted for the largest revenue share of 46.33% in 2024. These industries utilize spheroids for predictive toxicology, efficacy screening, and disease modeling. The demand for human-relevant, scalable 3D models drives their integration into R&D pipelines.
  • North America dominated the market due to its well-established regulatory frameworks and healthcare infrastructure. These facilitate the clinical translation and adoption of spheroid-based products, further propelling market growth.
  • Thermo Fisher Scientific Inc., Corning Incorporated, Merck KGaA, Lonza, InSphero AG, Greiner Bio-One International GmbH, 3D Biotek LLC, CN Bio Innovations, Kuraray Co., Ltd., and Tecan Group Ltd. are some of the market players operating in the market.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. Method
1.1.3. Source
1.1.4. Application
1.1.5. End Use
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Spheroids Market Variables and Trends
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. High adoption of spheroids in drug discovery
3.2.1.2. Technological advancements
3.2.1.3. Rising demand for tissue engineering & organ transplantation
3.2.2. Market restraint analysis
3.2.2.1. Challenges associated with 3D cell culturing
3.2.2.2. Ethical issues associated with spheroid cultures
3.3. Spheroids Market Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Type Business Analysis
4.1. Segment Dashboard
4.2. Global Spheroids Market: Type Movement Analysis
4.3. Global Spheroids Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
4.4. Multicellular tumor spheroids (MCTS)
4.4.1. MCTS market estimates and forecast, 2018-2030
4.5. Neurospheres
4.5.1. Neurospheres market estimates and forecast, 2018-2030
4.6. Mammospheres
4.6.1. Mammospheres market estimates and forecast, 2018-2030
4.7. Hepatospheres
4.7.1. Hepatospheres market estimates and forecast, 2018-2030
4.8. Embryoid bodies
4.8.1. Embryoid bodies market estimates and forecast, 2018-2030
Chapter 5. Method Business Analysis
5.1. Segment Dashboard
5.2. Global Spheroids Market: Method Movement Analysis
5.3. Global Spheroids Market Size & Trend Analysis, by Method, 2018 to 2030 (USD Million)
5.4. Micropatterned Plates
5.4.1. Micropatterned plates market estimates and forecast, 2018-2030
5.5. Low Cell Attachment Plates
5.5.1. Low cell attachment plates market estimates and forecast, 2018-2030
5.6. Hanging Drop Method
5.6.1. Hanging drop method market estimates and forecast, 2018-2030
5.7. Others
5.7.1. Other methods market estimates and forecast, 2018-2030
Chapter 6. Source Business Analysis
6.1. Segment Dashboard
6.2. Global Spheroids Market: Source Movement Analysis
6.3. Global Spheroids Market Size & Trend Analysis, by Source, 2018 to 2030 (USD Million)
6.4. Cell Line
6.4.1. Cell line market estimates and forecast, 2018-2030
6.5. Primary Cell
6.5.1. Primary cell market estimates and forecast, 2018-2030
6.6. iPSCs Derived Cells
6.6.1. iPSCs derived cells market estimates and forecast, 2018-2030
Chapter 7. End Use Business Analysis
7.1. Segment Dashboard
7.2. Global Spheroids Market: End Use Movement Analysis
7.3. Global Spheroids Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
7.4. Biotechnology and Pharmaceutical Industries
7.4.1. Biotechnology and pharmaceutical industries market estimates and forecast 2018 to 2030, (USD million)
7.5. Academic & Research Institutes
7.5.1. Academic & research institutes market estimates and forecast 2018 to 2030, (USD Million)
7.6. Hospitals and Diagnostic Centers
7.6.1. Hospitals and diagnostic centers market estimates and forecast 2018 to 2030, (USD million)
Chapter 8. Application Business Analysis
8.1. Segment Dashboard
8.2. Global Spheroids Market: Application Movement Analysis
8.3. Global Spheroids Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
8.4. Developmental Biology
8.4.1. Developmental biology market estimates and forecast 2018 to 2030, (USD million)
8.5. Personalized Medicine
8.5.1. Personalized medicine market estimates and forecast 2018 to 2030, (USD Million)
8.6. Regenerative Medicine
8.6.1. Regenerative medicine market estimates and forecast 2018 to 2030, (USD million)
8.7. Disease Pathology Studies
8.7.1. Disease pathology studies market estimates and forecast 2018 to 2030, (USD Million)
8.8. Drug Toxicity & Efficacy Testing
8.8.1. Drug toxicity & efficacy testing market estimates and forecast 2018 to 2030, (USD Million)
Chapter 9. Regional Business Analysis, by Country, Type, Method, Source, Application, & End Use
9.1. Segment Dashboard
9.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
9.3. North America
9.3.1. North America market estimates and forecast, 2018-2030 (USD Billion)
9.3.2. U.S.
9.3.2.1. Key Country Dynamics
9.3.2.2. Target Disease Prevalence
9.3.2.3. Competitive Scenario
9.3.2.4. U.S. Market estimates and forecast, 2018-2030 (USD Billion)
9.3.3. Canada
9.3.3.1. Key Country Dynamics
9.3.3.2. Target Disease Prevalence
9.3.3.3. Competitive Scenario
9.3.3.4. Canada Market estimates and forecast, 2018-2030 (USD Billion)
9.3.4. Mexico
9.3.4.1. Key Country Dynamics
9.3.4.2. Target Disease Prevalence
9.3.4.3. Competitive Scenario
9.3.4.4. Mexico Market estimates and forecast, 2018-2030 (USD Billion)
9.4. Europe
9.4.1. Europe Market estimates and forecast, 2018-2030 (USD Billion)
9.4.2. UK
9.4.2.1. Key Country Dynamics
9.4.2.2. Target Disease Prevalence
9.4.2.3. Competitive Scenario
9.4.2.4. UK Market estimates and forecast, 2018-2030 (USD Billion)
9.4.3. Germany
9.4.3.1. Key Country Dynamics
9.4.3.2. Target Disease Prevalence
9.4.3.3. Competitive Scenario
9.4.3.4. Germany Market estimates and forecast, 2018-2030 (USD Billion)
9.4.4. France
9.4.4.1. Key Country Dynamics
9.4.4.2. Target Disease Prevalence
9.4.4.3. Competitive Scenario
9.4.4.4. France Market estimates and forecast, 2018-2030 (USD Billion)
9.4.5. Italy
9.4.5.1. Key Country Dynamics
9.4.5.2. Target Disease Prevalence
9.4.5.3. Competitive Scenario
9.4.5.4. Italy Market estimates and forecast, 2018-2030 (USD Billion)
9.4.6. Spain
9.4.6.1. Key Country Dynamics
9.4.6.2. Target Disease Prevalence
9.4.6.3. Competitive Scenario
9.4.6.4. Spain Market estimates and forecast, 2018-2030 (USD Billion)
9.4.7. Denmark
9.4.7.1. Key Country Dynamics
9.4.7.2. Target Disease Prevalence
9.4.7.3. Competitive Scenario
9.4.7.4. Denmark Market estimates and forecast, 2018-2030 (USD Billion)
9.4.8. Sweden
9.4.8.1. Key Country Dynamics
9.4.8.2. Target Disease Prevalence
9.4.8.3. Competitive Scenario
9.4.8.4. Sweden Market estimates and forecast, 2018-2030 (USD Billion)
9.4.9. Norway
9.4.9.1. Key Country Dynamics
9.4.9.2. Target Disease Prevalence
9.4.9.3. Competitive Scenario
9.4.9.4. Norway Market estimates and forecast, 2018-2030 (USD Billion)
9.5. Asia Pacific
9.5.1. Asia Pacific Market estimates and forecast, 2018-2030 (USD Billion)
9.5.2. China
9.5.2.1. Key Country Dynamics
9.5.2.2. Target Disease Prevalence
9.5.2.3. Competitive Scenario
9.5.2.4. China Market estimates and forecast, 2018-2030 (USD Billion)
9.5.3. Japan
9.5.3.1. Key Country Dynamics
9.5.3.2. Target Disease Prevalence
9.5.3.3. Competitive Scenario
9.5.3.4. Japan Market estimates and forecast, 2018-2030 (Volume, Thousand)
9.5.4. India
9.5.4.1. Key Country Dynamics
9.5.4.2. Target Disease Prevalence
9.5.4.3. Competitive Scenario
9.5.4.4. India Market estimates and forecast, 2018-2030 (USD Billion)
9.5.5. Australia
9.5.5.1. Key Country Dynamics
9.5.5.2. Target Disease Prevalence
9.5.5.3. Competitive Scenario
9.5.5.4. Australia Market estimates and forecast, 2018-2030 (USD Billion)
9.5.6. Thailand
9.5.6.1. Key Country Dynamics
9.5.6.2. Target Disease Prevalence
9.5.6.3. Competitive Scenario
9.5.6.4. Thailand Market estimates and forecast, 2018-2030 (USD Billion)
9.5.7. South Korea
9.5.7.1. Key Country Dynamics
9.5.7.2. Target Disease Prevalence
9.5.7.3. Competitive Scenario
9.5.7.4. South Korea Market estimates and forecast, 2018-2030 (USD Billion)
9.6. Latin America
9.6.1. Latin America Market estimates and forecast, 2018-2030 (USD Billion)
9.6.2. Brazil
9.6.2.1. Key Country Dynamics
9.6.2.2. Target Disease Prevalence
9.6.2.3. Competitive Scenario
9.6.2.4. Brazil Market estimates and forecast, 2018-2030 (USD Billion)
9.6.3. Argentina
9.6.3.1. Key Country Dynamics
9.6.3.2. Target Disease Prevalence
9.6.3.3. Competitive Scenario
9.6.3.4. Argentina Market estimates and forecast, 2018-2030 (USD Billion)
9.7. MEA
9.7.1. MEA Market estimates and forecast, 2018-2030 (USD Billion)
9.7.2. Saudi Arabia
9.7.2.1. Key Country Dynamics
9.7.2.2. Target Disease Prevalence
9.7.2.3. Competitive Scenario
9.7.2.4. Saudi Arabia Market estimates and forecast, 2018-2030 (USD Billion)
9.7.3. South Africa
9.7.3.1. Key Country Dynamics
9.7.3.2. Target Disease Prevalence
9.7.3.3. Competitive Scenario
9.7.3.4. South Africa Market estimates and forecast, 2018-2030 (USD Billion)
9.7.4. UAE
9.7.4.1. Key Country Dynamics
9.7.4.2. Target Disease Prevalence
9.7.4.3. Competitive Scenario
9.7.4.4. UAE Market estimates and forecast, 2018-2030 (USD Billion)
9.7.5. Kuwait
9.7.5.1. Key Country Dynamics
9.7.5.2. Target Disease Prevalence
9.7.5.3. Competitive Scenario
9.7.5.4. Kuwait Market estimates and forecast, 2018-2030 (USD Billion)
Chapter 10. Competitive Landscape
10.1. Company Categorization
10.2. Strategy Mapping
10.3. Company Position Analysis, 2024
10.4. Company Profiles/Listing
10.4.1. Thermo Fisher Scientific, Inc.
10.4.1.1. Company overview
10.4.1.2. Financial performance
10.4.1.3. Product benchmarking
10.4.1.4. Strategic initiatives
10.4.2. Merck KGaA
10.4.2.1. Company overview
10.4.2.2. Financial performance
10.4.2.3. Product benchmarking
10.4.2.4. Strategic initiatives
10.4.3. Lonza
10.4.3.1. Company overview
10.4.3.2. Financial performance
10.4.3.3. Product benchmarking
10.4.3.4. Strategic initiatives
10.4.4. CN Bio Innovations
10.4.4.1. Company overview
10.4.4.2. Financial performance
10.4.4.3. Product benchmarking
10.4.4.4. Strategic initiatives
10.4.5. 3D Biotek LLC
10.4.5.1. Company overview
10.4.5.2. Financial performance
10.4.5.3. Product benchmarking
10.4.5.4. Strategic initiatives
10.4.6. Kuraray Co., Ltd.
10.4.6.1. Company overview
10.4.6.2. Financial performance
10.4.6.3. Product benchmarking
10.4.6.4. Strategic initiatives
10.4.7. Tecan Group Ltd.
10.4.7.1. Company overview
10.4.7.2. Financial performance
10.4.7.3. Product benchmarking
10.4.7.4. Strategic initiatives
10.4.8. Corning Incorporated
10.4.8.1. Company overview
10.4.8.2. Financial performance
10.4.8.3. Product benchmarking
10.4.8.4. Strategic initiatives
10.4.9. Greiner Bio-One
10.4.9.1. Company overview
10.4.9.2. Financial performance
10.4.9.3. Product benchmarking
10.4.9.4. Strategic initiatives
10.4.10. InSphero
10.4.10.1. Company overview
10.4.10.2. Financial performance
10.4.10.3. Product benchmarking
10.4.10.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviation
Table 2 North America spheroids market, by type, 2018-2030 (USD Million)
Table 3 North America spheroids market, by method, 2018-2030 (USD Million)
Table 4 North America spheroids market, by source, 2018-2030 (USD Million)
Table 5 North America spheroids market, by End Use, 2018-2030 (USD Million)
Table 6 North America spheroids market, by application, 2018-2030 (USD Million)
Table 7 North America spheroids market, by region, 2018-2030 (USD Million)
Table 8 U.S. spheroids market, by type, 2018-2030 (USD Million)
Table 9 U.S. spheroids market, by method, 2018-2030 (USD Million)
Table 10 U.S. spheroids market, by source, 2018-2030 (USD Million)
Table 11 U.S. spheroids market, by End Use, 2018-2030 (USD Million)
Table 12 U.S. spheroids market, by application, 2018-2030 (USD Million)
Table 13 Canada spheroids market, by type, 2018-2030 (USD Million)
Table 14 Canada spheroids market, by method, 2018-2030 (USD Million)
Table 15 Canada spheroids market, by source, 2018-2030 (USD Million)
Table 16 Canada spheroids market, by End Use, 2018-2030 (USD Million)
Table 17 Canada spheroids market, by application, 2018-2030 (USD Million)
Table 18 Mexico spheroids market, by type, 2018-2030 (USD Million)
Table 19 Mexico spheroids market, by method, 2018-2030 (USD Million)
Table 20 Mexico spheroids market, by source, 2018-2030 (USD Million)
Table 21 Mexico spheroids market, by End Use, 2018-2030 (USD Million)
Table 22 Mexico spheroids market, by application, 2018-2030 (USD Million)
Table 23 Europe spheroids market, by type, 2018-2030 (USD Million)
Table 24 Europe spheroids market, by method, 2018-2030 (USD Million)
Table 25 Europe spheroids market, by source, 2018-2030 (USD Million)
Table 26 Europe spheroids market, by End Use, 2018-2030 (USD Million)
Table 27 Europe spheroids market, by application, 2018-2030 (USD Million)
Table 28 Europe spheroids market, by region, 2018-2030 (USD Million)
Table 29 Germany spheroids market, by type, 2018-2030 (USD Million)
Table 30 Germany spheroids market, by method, 2018-2030 (USD Million)
Table 31 Germany spheroids market, by source, 2018-2030 (USD Million)
Table 32 Germany spheroids market, by End Use, 2018-2030 (USD Million)
Table 33 Germany spheroids market, by application, 2018-2030 (USD Million)
Table 34 UK spheroids market, by type, 2018-2030 (USD Million)
Table 35 UK spheroids market, by method, 2018-2030 (USD Million)
Table 36 UK spheroids market, by source, 2018-2030 (USD Million)
Table 37 UK spheroids market, by End Use, 2018-2030 (USD Million)
Table 38 UK spheroids market, by application, 2018-2030 (USD Million)
Table 39 France spheroids market, by type, 2018-2030 (USD Million)
Table 40 France spheroids market, by method, 2018-2030 (USD Million)
Table 41 France spheroids market, by source, 2018-2030 (USD Million)
Table 42 France spheroids market, by End Use, 2018-2030 (USD Million)
Table 43 France spheroids market, by application, 2018-2030 (USD Million)
Table 44 Italy spheroids market, by type, 2018-2030 (USD Million)
Table 45 Italy spheroids market, by method, 2018-2030 (USD Million)
Table 46 Italy spheroids market, by source, 2018-2030 (USD Million)
Table 47 Italy spheroids market, by End Use, 2018-2030 (USD Million)
Table 48 Italy spheroids market, by application, 2018-2030 (USD Million)
Table 49 Spain spheroids market, by type, 2018-2030 (USD Million)
Table 50 Spain spheroids market, by method, 2018-2030 (USD Million)
Table 51 Spain spheroids market, by source, 2018-2030 (USD Million)
Table 52 Spain spheroids market, by End Use, 2018-2030 (USD Million)
Table 53 Spain spheroids market, by application, 2018-2030 (USD Million)
Table 54 Sweden spheroids market, by type, 2018-2030 (USD Million)
Table 55 Sweden spheroids market, by method, 2018-2030 (USD Million)
Table 56 Sweden spheroids market, by source, 2018-2030 (USD Million)
Table 57 Sweden spheroids market, by End Use, 2018-2030 (USD Million)
Table 58 Sweden spheroids market, by application, 2018-2030 (USD Million)
Table 59 Norway spheroids market, by type, 2018-2030 (USD Million)
Table 60 Norway spheroids market, by method, 2018-2030 (USD Million)
Table 61 Norway spheroids market, by source, 2018-2030 (USD Million)
Table 62 Norway spheroids market, by End Use, 2018-2030 (USD Million)
Table 63 Norway spheroids market, by application, 2018-2030 (USD Million)
Table 64 Denmark spheroids market, by type, 2018-2030 (USD Million)
Table 65 Denmark spheroids market, by method, 2018-2030 (USD Million)
Table 66 Denmark spheroids market, by source, 2018-2030 (USD Million)
Table 67 Denmark spheroids market, by End Use, 2018-2030 (USD Million)
Table 68 Denmark spheroids market, by application, 2018-2030 (USD Million)
Table 69 APAC spheroids market, by type, 2018-2030 (USD Million)
Table 70 APAC spheroids market, by method, 2018-2030 (USD Million)
Table 71 APAC spheroids market, by source, 2018-2030 (USD Million)
Table 72 APAC spheroids market, by End Use, 2018-2030 (USD Million)
Table 73 APAC spheroids market, by application, 2018-2030 (USD Million)
Table 74 APAC spheroids market, by region, 2018-2030 (USD Million)
Table 75 China spheroids market, by type, 2018-2030 (USD Million)
Table 76 China spheroids market, by method, 2018-2030 (USD Million)
Table 77 China spheroids market, by source, 2018-2030 (USD Million)
Table 78 China spheroids market, by End Use, 2018-2030 (USD Million)
Table 79 China spheroids market, by application, 2018-2030 (USD Million)
Table 80 Japan spheroids market, by type, 2018-2030 (USD Million)
Table 81 Japan spheroids market, by method, 2018-2030 (USD Million)
Table 82 Japan spheroids market, by source, 2018-2030 (USD Million)
Table 83 Japan spheroids market, by End Use, 2018-2030 (USD Million)
Table 84 Japan spheroids market, by application, 2018-2030 (USD Million)
Table 85 India spheroids market, by type, 2018-2030 (USD Million)
Table 86 India spheroids market, by method, 2018-2030 (USD Million)
Table 87 India spheroids market, by source, 2018-2030 (USD Million)
Table 88 India spheroids market, by End Use, 2018-2030 (USD Million)
Table 89 India spheroids market, by application, 2018-2030 (USD Million)
Table 90 Thailand spheroids market, by type, 2018-2030 (USD Million)
Table 91 Thailand spheroids market, by method, 2018-2030 (USD Million)
Table 92 Thailand spheroids market, by source, 2018-2030 (USD Million)
Table 93 Thailand spheroids market, by End Use, 2018-2030 (USD Million)
Table 94 Thailand spheroids market, by application, 2018-2030 (USD Million)
Table 95 South Korea spheroids market, by type, 2018-2030 (USD Million)
Table 96 South Korea spheroids market, by method, 2018-2030 (USD Million)
Table 97 South Korea spheroids market, by source, 2018-2030 (USD Million)
Table 98 South Korea spheroids market, by End Use, 2018-2030 (USD Million)
Table 99 South Korea spheroids market, by application, 2018-2030 (USD Million)
Table 100 Australia spheroids market, by type, 2018-2030 (USD Million)
Table 101 Australia spheroids market, by method, 2018-2030 (USD Million)
Table 102 Australia spheroids market, by source, 2018-2030 (USD Million)
Table 103 Australia spheroids market, by End Use, 2018-2030 (USD Million)
Table 104 Australia spheroids market, by application, 2018-2030 (USD Million)
Table 105 Latin America spheroids market, by type, 2018-2030 (USD Million)
Table 106 Latin America spheroids market, by method, 2018-2030 (USD Million)
Table 107 Latin America spheroids market, by source, 2018-2030 (USD Million)
Table 108 Latin America spheroids market, by End Use, 2018-2030 (USD Million)
Table 109 Latin America spheroids market, by application, 2018-2030 (USD Million)
Table 110 Latin America spheroids market, by region, 2018-2030 (USD Million)
Table 111 Brazil spheroids market, by type, 2018-2030 (USD Million)
Table 112 Brazil spheroids market, by method, 2018-2030 (USD Million)
Table 113 Brazil spheroids market, by source, 2018-2030 (USD Million)
Table 114 Brazil spheroids market, by End Use, 2018-2030 (USD Million)
Table 115 Brazil spheroids market, by application, 2018-2030 (USD Million)
Table 116 Argentina spheroids market, by type, 2018-2030 (USD Million)
Table 117 Argentina spheroids market, by method, 2018-2030 (USD Million)
Table 118 Argentina spheroids market, by source, 2018-2030 (USD Million)
Table 119 Argentina spheroids market, by End Use, 2018-2030 (USD Million)
Table 120 Argentina spheroids market, by application, 2018-2030 (USD Million)
Table 121 Middle East and Africa spheroids market, by type, 2018-2030 (USD Million)
Table 122 Middle East and Africa spheroids market, by method, 2018-2030 (USD Million)
Table 123 Middle East and Africa spheroids market, by source, 2018-2030 (USD Million)
Table 124 Middle East and Africa spheroids market, by End Use, 2018-2030 (USD Million)
Table 125 Middle East and Africa spheroids market, by application, 2018-2030 (USD Million)
Table 126 Middle East and Africa spheroids market, by region, 2018-2030 (USD Million)
Table 127 South Africa spheroids market, by type, 2018-2030 (USD Million)
Table 128 South Africa spheroids market, by method, 2018-2030 (USD Million)
Table 129 South Africa spheroids market, by source, 2018-2030 (USD Million)
Table 130 South Africa spheroids market, by End Use, 2018-2030 (USD Million)
Table 131 South Africa spheroids market, by application, 2018-2030 (USD Million)
Table 132 Saudi Arabia spheroids market, by type, 2018-2030 (USD Million)
Table 133 Saudi Arabia spheroids market, by method, 2018-2030 (USD Million)
Table 134 Saudi Arabia spheroids market, by source, 2018-2030 (USD Million)
Table 135 Saudi Arabia spheroids market, by End Use, 2018-2030 (USD Million)
Table 136 Saudi Arabia spheroids market, by application, 2018-2030 (USD Million)
Table 137 UAE spheroids market, by type, 2018-2030 (USD Million)
Table 138 UAE spheroids market, by method, 2018-2030 (USD Million)
Table 139 UAE spheroids market, by source, 2018-2030 (USD Million)
Table 140 UAE spheroids market, by End Use, 2018-2030 (USD Million)
Table 141 UAE spheroids market, by application, 2018-2030 (USD Million)
Table 142 Kuwait spheroids market, by type, 2018-2030 (USD Million)
Table 143 Kuwait spheroids market, by method, 2018-2030 (USD Million)
Table 144 Kuwait spheroids market, by source, 2018-2030 (USD Million)
Table 145 Kuwait spheroids market, by End Use, 2018-2030 (USD Million)
Table 146 Kuwait spheroids market, by application, 2018-2030 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value-chain-based sizing & forecasting
Figure 6 QFD modeling for market share assessment
Figure 7 Market formulation & validation
Figure 8 Spheroids: market outlook
Figure 9 Spheroids competitive insights
Figure 10 Parent market outlook
Figure 11 Related/ancillary market outlook
Figure 12 Spheroids market driver impact
Figure 13 Spheroids market restraint impact
Figure 14 Spheroids market strategic initiatives analysis
Figure 15 Spheroids market: type movement analysis
Figure 16 Spheroids market: type outlook and key takeaways
Figure 17 MCTS market estimates and forecast, 2018-2030
Figure 18 Neurospheres market estimates and forecast, 2018-2030
Figure 19 Mammospheres market estimates and forecast, 2018-2030
Figure 20 Hepatospheres market estimates and forecast, 2018-2030
Figure 21 Embryoid bodies market estimates and forecast, 2018-2030
Figure 22 Spheroids market: method movement analysis
Figure 23 Spheroids market: method outlook and key takeaways
Figure 24 Micropatterned plates market estimates and forecast, 2018-2030
Figure 25 Low cell attachment plates market estimates and forecast, 2018-2030
Figure 26 Hanging drop method for spheroid culture market estimates and forecast, 2018-2030
Figure 27 Other methods for spheroid culture market estimates and forecast, 2018-2030
Figure 28 Spheroids market: source movement analysis
Figure 29 Spheroids market: source outlook and key takeaways
Figure 30 Cell line market estimates and forecast, 2018-2030
Figure 31 Primary cell market estimates and forecast, 2018-2030
Figure 32 iPSCs derived cells market estimates and forecast, 2018-2030
Figure 33 Spheroids market: End Use movement analysis
Figure 34 Spheroids market: End Use outlook and key takeaways
Figure 35 Biotechnology and pharmaceutical industries market estimates and forecast, 2018-2030
Figure 36 Academic & research institutes market estimates and forecast, 2018-2030
Figure 37 Hospitals and diagnostic centers market estimates and forecast, 2018-2030
Figure 38 Spheroids market: application movement analysis
Figure 39 Spheroids market: application outlook and key takeaways
Figure 40 Developmental biology market estimates and forecast, 2018-2030
Figure 41 Personalized medicine market estimates and forecast, 2018-2030
Figure 42 Regenerative medicine market estimates and forecast, 2018-2030
Figure 43 Disease pathology studies market estimates and forecast, 2018-2030
Figure 44 Drug toxicity & efficacy testing market estimates and forecast, 2018-2030
Figure 45 Global Spheroids market: regional movement analysis
Figure 46 Global Spheroids market: regional outlook and key takeaways
Figure 47 North America
Figure 48 North America market estimates and forecast, 2018-2030
Figure 49 U.S. key country dynamics
Figure 50 U.S. market estimates and forecast, 2018-2030
Figure 51 Canada key country dynamics
Figure 52 Canada market estimates and forecast, 2018-2030
Figure 53 Mexico key country dynamics
Figure 54 Mexico market estimates and forecast, 2018-2030
Figure 55 Europe
Figure 56 Europe. market estimates and forecast, 2018-2030
Figure 57 UK key country dynamics
Figure 58 UK market estimates and forecast, 2018-2030
Figure 59 Germany key country dynamics
Figure 60 Germany market estimates and forecast, 2018-2030
Figure 61 France key country dynamics
Figure 62 France market estimates and forecast, 2018-2030
Figure 63 Italy key country dynamics
Figure 64 Italy market estimates and forecast, 2018-2030
Figure 65 Spain key country dynamics
Figure 66 Spain market estimates and forecast, 2018-2030
Figure 67 Sweden key country dynamics
Figure 68 Sweden market estimates and forecast, 2018-2030
Figure 69 Norway key country dynamics
Figure 70 Norway market estimates and forecast, 2018-2030
Figure 71 Denmark key country dynamics
Figure 72 Denmark market estimates and forecast, 2018-2030
Figure 73 Asia Pacific
Figure 74 Asia Pacific market estimates and forecast, 2018-2030
Figure 75 China key country dynamics
Figure 76 China market estimates and forecast, 2018-2030
Figure 77 Japan key country dynamics
Figure 78 Japan market estimates and forecast, 2018-2030
Figure 79 India key country dynamics
Figure 80 India market estimates and forecast, 2018-2030
Figure 81 Australia key country dynamics
Figure 82 Australia market estimates and forecast, 2018-2030
Figure 83 Thailand key country dynamics
Figure 84 Thailand market estimates and forecast, 2018-2030
Figure 85 South Korea key country dynamics
Figure 86 South Korea market estimates and forecast, 2018-2030
Figure 87 Latin America
Figure 88 Latin America market estimates and forecast, 2018-2030
Figure 89 Brazil key country dynamics
Figure 90 Brazil market estimates and forecast, 2018-2030
Figure 91 Argentina key country dynamics
Figure 92 Argentina market estimates and forecast, 2018-2030
Figure 93 Middle East and Africa
Figure 94 Middle East and Africa. market estimates and forecast, 2018-2030
Figure 95 Saudi Arabia key country dynamics
Figure 96 Saudi Arabia market estimates and forecast, 2018-2030
Figure 97 South Africa key country dynamics
Figure 98 South Africa market estimates and forecast, 2018-2030
Figure 99 UAE key country dynamics
Figure 100 UAE market estimates and forecast, 2018-2030
Figure 101 Kuwait key country dynamics
Figure 102 Kuwait market estimates and forecast, 2018-2030

Companies Mentioned

The major companies featured in this Spheroids market report include:
  • Thermo Fisher Scientific Inc.
  • Corning Incorporated
  • Merck KGaA
  • Lonza Group AG
  • InSphero AG
  • Greiner Bio-One International GmbH
  • 3D Biotek LLC
  • CN Bio Innovations
  • Kuraray Co., Ltd.
  • Tecan Group Ltd.

Related Topics

Related Reports

Cell Culture Media Market for Regenerative Medicines Market Report 2025 - Product Image

Cell Culture Media Market for Regenerative Medicines Market Report 2025

  • Report
  • 250 Pages
  • Global
From
3D Spheroids Market - Global Forecast 2025-2030 - Product Image

3D Spheroids Market - Global Forecast 2025-2030

  • Report
  • 192 Pages
  • Global
From
Spheroids Market - Global Industry Size, Share, Trends, Opportunity & Forecast, 2020-2030F - Product Image

Spheroids Market - Global Industry Size, Share, Trends, Opportunity & Forecast, 2020-2030F

  • Report
  • 183 Pages
  • Global
From
3D Cell Culture Staining Kit Market - Global Forecast 2025-2030 - Product Image

3D Cell Culture Staining Kit Market - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
Microfluidics in Cell Biology: Part A: Microfluidics for Multicellular Systems. Methods in Cell Biology Volume 146 - Product Image

Microfluidics in Cell Biology: Part A: Microfluidics for Multicellular Systems. Methods in Cell Biology Volume 146

  • Book
Copyright © 2002-2025 Research and Markets. All Rights Reserved.